logo
Select company
Select metric
0%Interest Expense Margin
VS
Market
73
Sector
66
Industry
52
History
-
$ 3.7Close
$ 0.88 - $ 4.74 52-Week Range
Ticker Information

Ticker

PYXS

Company Name

PYXIS ONCOLOGY INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

PYXIS ONCOLOGY INC - Interest Expense Margin Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

PYXS - Int. Exp. % Historical data
DateInterest ExpenseInterest Expense MarginRevenues
6/30/2025$ 00%$ 2.82M
3/31/2025$ 00%$ 0
12/31/2024$ 00%$ 16.15M
9/30/2024$ 00%$ 16.15M
6/30/2024$ 00%$ 16.15M
3/31/2024$ 00%$ 16.15M
12/31/2023$ 00%$ 0
9/30/2023$ 00%$ 0
6/30/2023$ 00%$ 0
3/31/2023$ 00%$ 0
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • PYXIS ONCOLOGY INC's latest trailing twelve months (TTM) Int. Exp. % stands at 0%.
  • Over the past 5 years, PYXIS ONCOLOGY INC's average Int. Exp. % has been 0%.
  • The median Int. Exp. % for PYXIS ONCOLOGY INC during this period was 0%
  • PYXIS ONCOLOGY INC reached its highest Int. Exp. % over the past 5 years at 0%.
  • The lowest Int. Exp. % recorded by PYXIS ONCOLOGY INC in the same timeframe 0%

PYXIS ONCOLOGY INC's Int. Exp. % vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Int. Exp. % Benchmarks
CompanyInt. Exp. %
NTRB : NUTRIBAND INC 0.75%ALGS : ALIGOS THERAPEUTICS INC 389.98%STTK : SHATTUCK LABS INC 0%ORMP : ORAMED PHARMACEUTICALS INC -640.4%CAMP : CAMP4 THERAPEUTICS CORP 0%ARMP : ARMATA PHARMACEUTICALS INC 323.5%DTIL : PRECISION BIOSCIENCES INC 107.85%NRXS : NEURAXIS INC 2.57%CBUS : CIBUS INC 704.85%ABVC : ABVC BIOPHARMA INC 59.7%

Definition of Interest Expense Margin

[Calculation] The company’s interest expenses [IntExp] expressed as a percentage of [Revenue].
Int. Exp. / Revenues
(=) Int. Exp. %
Int. Exp. % for PYXIS ONCOLOGY INC is calculated as follows: Int. Exp. [ $ 0 ] / Revenues [ $ 0 ]
(=) Int. Exp. % [ 0% ]

PYXS - Interest Expense Margin, Last 5 years

0%

Minimum

Mar 31, 2024

0%

Maximum

Mar 31, 2024

0%

Average

0%

Median

Int. Exp. % Benchmark Analysis

The chart above depicts the distribution of Int. Exp. % for companies in the Total Stock Market. The average Int. Exp. % of the companies is 1.62% with a standard deviation of 2.19%.
The following table provides additional summary stats:
Int. Exp. % in the Market:
filtered constituents3.15K
min-4.94%
max8.48%
average1.62%
median0.79%
std2.19%